单向式全胸腔镜肺叶切除手术治疗肺良性疾病的可行性和安全性分析

To analyse the feasibility and safety of single-direction video-assisted thoracoscopic lobectomy in the treatment of benign pulmonary diseases

目的探讨单向式全胸腔镜肺叶切除手术治疗肺良性疾病的可行性和安全性。方法选取我院胸外科86例肺良性疾病患者,随机分为传统开胸肺叶切除术组(开胸组)和单向式全胸腔镜肺叶切除术组(胸腔镜组),每组各43例,比较两组患者平均手术时间、术中失血量、术后胸腔引流量、疼痛评分、住院天数及术后并发症发生情况,随访观察两组术后1年无瘤生存率。结果 86例患者均顺利完成手术,在平均手术时间上胸腔镜组与开胸组比较,差异无统计学意义(P>0.05);在术中失血量、术后胸腔引流量、切口疼痛评分、术后住院时间及术后并发症的发生情况上胸腔镜组明显低于开胸组(P<0.05),在术后1年无瘤生存率胸腔镜组与开胸组比较,差异无统计学意义(P>0.05)。结论单向式全胸腔镜肺叶切除手术治疗肺良性疾病是可行的、安全的、有效的,值得临床应用和推广。

Objective To explore the feasibility and safeyof of Single-direction video-assisted thoracoscopic lobectomy in the treatment of benign pulmonary diseases. Methods Select 86 cases of thoracic surgery in lungs benign disease patients, ran- domly divided into conventional thoracotomy lobectomy group （open group） and single-direction video-assisted thoracoscopic lu- bectomy group （ thoracoscope group）, each group of the 43 cases, the average length of operative time, tile loss of intraoperative blood, the lead flow of postoperative chest, the score of pain, tile day of hospitalization and the postoperative complications, the rate of follow-up postoperative 1 year disease-free were comared between two groups. Results 86 patients were successfully completed surgery. There were no significant difference between open group and thoracoscope group in the average length of operative time and the rate of postoperative 1 year disease-free;the loss of intraoperative blood, the lead flow of postoperative chest, the score of pain ,the day of hospitalization and the postoperative complications thoracoscope group was significantly lower than the open group （ P 〈 0. 05）. Conclusion Single-direction video-assisted thoraeoscopic lobectomy in the treatment of benign pulmonary diseases is feasible, safe and effective, it is worth clinical application and popularization.